Clinical Trials in West Virginia (WV) | West Virginia Clinical Drug Trials & Studies

You are viewing Clinical Trials In West Virginia

Have multiple conditions? Click here

Showing 1-100 of 407

There are 407 trials in West Virginia

Name	City	State	Zip
Low Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone for Prostate Cancer	Wheeling	WV	26003
Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial	Wheeling	WV	26003
Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial	Wheeling	WV	26003
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Wheeling	WV	26003
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery	Wheeling	WV	26003
Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer	Wheeling	WV	26003
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy	Wheeling	WV	26003
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma	Wheeling	WV	26003
Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer	Wheeling	WV	26003
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer	Wheeling	WV	26003
Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma	Wheeling	WV	26003
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer	Wheeling	WV	26003
Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer	Wheeling	WV	26003
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy	Wheeling	WV	26003
Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer	Wheeling	WV	26003
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery	Wheeling	WV	26003
Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma	Wheeling	WV	26003
Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery	Wheeling	WV	26003
Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer	Wheeling	WV	26003
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting	Wheeling	WV	26003
Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer	Wheeling	WV	26003
Creighton Model Effectiveness, Intentions and Behaviors Assessment (CEIBA)	Weirton	WV	26062
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Princeton	WV	24740
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer	Princeton	WV	24740
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy	Princeton	WV	24740
Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer	Princeton	WV	24740
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery	Princeton	WV	24740
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer	Princeton	WV	24740
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery	Princeton	WV	24740
Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer	Parkersburg	WV	26102
Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer	Parkersburg	WV	26102
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Parkersburg	WV	26102
Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy	Parkersburg	WV	26102
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy	Parkersburg	WV	26102
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia	Parkersburg	WV	26102
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement	Parkersburg	WV	26102
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer	Parkersburg	WV	26102
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer	Parkersburg	WV	26102
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer	Parkersburg	WV	26102
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery	Parkersburg	WV	26102
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer	Parkersburg	WV	26101
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)	Morgantown	WV
The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-term Safety and Tolerability of TMC125 Combined With Other Antiretroviral Drugs.	Morgantown	WV
Post-marketing, Observational Study of HUMIRAÂ® (Adalimumab) in Patients With Chronic Plaque Psoriasis (Ps)	Morgantown	WV
Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC	Morgantown	WV
Medtronic Shock-Less Study	Morgantown	WV
A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic DMARDs	Morgantown	WV
A Prospective Clinical Outcomes Registry	Morgantown	WV
Open-label Study to Assess the Safety and Efficacy of CDP6038 in Patients Who Completed RA0056	Morgantown	WV
A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One TNF-Inhibitor	Morgantown	WV
Adaptive Cardiac Resynchronization Therapy Study	Morgantown	WV
Golimumab in Rheumatoid Arthritis Patients With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)	Morgantown	WV
A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus	Morgantown	WV
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza	Morgantown	WV
Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout	Morgantown	WV
Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment	Morgantown	WV
Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Comorbidities	Morgantown	WV
Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to Cimzia	Morgantown	WV
Conversion to Embeda With Rescue Trial	Morgantown	WV
MP-376 (Aeroquinâ„¢, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis	Morgantown	WV
Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy	Morgantown	WV
Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer	Morgantown	WV	26505
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer	Morgantown	WV	26506
A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor	Morgantown	WV	26506
Safety Escalating Repeat IV, in Stroke Patients	Morgantown	WV	26506
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease	Morgantown	WV	26506
A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)	Morgantown	WV	26506
Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD)	Morgantown	WV	26506
Ofatumumab and Bendamustine Combination Therapy Compared With Bendamustine Monotherapy in Indolent B-cell Non-Hodgkin's Lymphoma (NHL) Unresponsive to Rituximab or a Rituximab-Containing Regimen	Morgantown	WV	26506
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies	Morgantown	WV
A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder	Morgantown	WV
Biomarkers of Anti-TNF-Î± Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients	Morgantown	WV
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer	Morgantown	WV	26506
A Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin's Lymphoma	Morgantown	WV	26506
Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer	Morgantown	WV	26506
BAY 43-9006 Plus Paclitaxel/Carboplatin in Women With GYN Tumors	Morgantown	WV	26506
Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma	Morgantown	WV	26506
Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer	Morgantown	WV	26506
Compassionate Use of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES)	Morgantown	WV	26506
Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia	Morgantown	WV	26506
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery	Morgantown	WV	26506
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer	Morgantown	WV	26506
EXTEND (Eltrombopag Extended Dosing Study)	Morgantown	WV	26506
Study To Assess Long Term Safety Of Pazopanib	Morgantown	WV	26506
Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy	Morgantown	WV	26506
Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer	Morgantown	WV	26506
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery	Morgantown	WV	26506
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer	Morgantown	WV	26506
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia	Morgantown	WV	26506
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma	Morgantown	WV	26506
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy	Morgantown	WV	26506
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients	Morgantown	WV	26506
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)	Morgantown	WV	26506
A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor	Morgantown	WV	26506
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US	Morgantown	WV	26506
A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia	Morgantown	WV	26506
A Study to Examine the Effects of Low and High-fat Meals on Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients	Morgantown	WV	26506
Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma	Morgantown	WV	26506
Phase II Study of Ofatumumab Plus ICE or DHAP Chemotherapy Regimen in Relapsed/ Refractory DLBCL	Morgantown	WV	26506
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia	Morgantown	WV	26506

View Clinical Trial Facilities in West Virginia

Showing 1-100 of 407